Other markers that were still different in PWH and uninfected individuals after 2 years of therapy included higher expression of NKG2C on CD56dim cells, likely due to CMV infection in HIV-infected individuals which is known to upregulate NKG2C (34). The gene discussed is KLRC2; the disease is cytomegalovirus infection.